BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Varex Imaging Announces Financial Results for Fourth Quarter and Fiscal Year 2017

  Revenues increased 13% to $698M, including $61M from the acquired imaging business

  November 9, 2017

   · 

  30 min read
• Business

  Sangamo Announces Strategic Investment in Manufacturing and Appointment of Andy Ramelmeier as Head of Technical Operations

  Sangamo’s strategic investment in large scale manufacturing capacity and capabilities represents a balanced approach to meet the needs of its rapidly expanding pipeline of genomic therapy product candidates.

  November 9, 2017

   · 

  4 min read
• Business

  Endo Reports Third-Quarter 2017 Financial Results

  Revenues of $787M, an 11 percent decrease compared to third-quarter 2016 revenues of $884M.

  November 9, 2017

   · 

  107 min read
• Business

  Pfenex Reports Third Quarter 2017 Results, Interim PK Data From PF708 Study, Completion of Process Development Milestone on Jazz Program and Provides Business Update

  Using the patented Pfenex Expression Technology platform, the Company has created an advanced pipeline of therapeutic equivalents, vaccines, biologics and biosimilars.

  November 9, 2017

   · 

  18 min read
• Business

  Biocept Reports Third Quarter 2017 Financial Results

  Biocept reports financial results for the three and nine months ended September 30, 2017, and provides an update on its business progress.

  November 9, 2017

   · 

  18 min read
• Business

  BioLife Solutions Announces Third Quarter 2017 Financial Results

  Revenue from biopreservation media product sales for the third quarter of 2017 was a new record of $3M, an increase of 39% compared with the third quarter of 2016.

  November 9, 2017

   · 

  18 min read
• Business

  CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017

  Total Q3 2017 revenues increased 59% to $3.8M, which includes both product sales and grant income, up from $2.4M in Q3 2016.

  November 9, 2017

   · 

  29 min read
• Business

  Arcadia Biosciences Announces Third-Quarter and Nine-Month 2017 Financial Results and Business Highlights

  Revenues for the quarter were $589,000, 45 percent lower than the $1.1 million for the third quarter of 2016.

  November 9, 2017

   · 

  11 min read
• FDA

  Heron Therapeutics Announces FDA Approval of CINVANTI Injectable Emulsion for the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting

  The drug is the first and only polysorbate 80-free, IV formulation of an nk1 receptor antagonist indicated for the prevention of acute and delayed CINV.

  November 9, 2017

   · 

  12 min read
• Business

  Ligand Reports Third Quarter 2017 Financial Results

  Total revenues for the third quarter of 2017 were $33.4 million, compared with $21.6 million for the same period in 2016.

  November 9, 2017

   · 

  23 min read